• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用口蹄疫病毒本地分离株制备纯化疫苗及其在犊牛中的免疫反应。

Preparation of purified vaccine from local isolate of foot and mouth disease virus and its immune response in bovine calves.

作者信息

Razak Abdul, Altaf Imran, Ahmad Anjum Aftab, Raza Awan Ali

机构信息

Institute of Microbiology, University of Veterinary and Animal Sciences, Syed Abdul Qadir Jillani (Out Fall) Road, Lahore 54000, Pakistan.

Institute of Biochemistry, and Biotechnology, University of Veterinary, and Animal Sciences, Syed Abdul Qadir Jillani (Out Fall) Road, Lahore 54000, Pakistan.

出版信息

Saudi J Biol Sci. 2023 Jul;30(7):103709. doi: 10.1016/j.sjbs.2023.103709. Epub 2023 Jun 16.

DOI:10.1016/j.sjbs.2023.103709
PMID:37440959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10333673/
Abstract

Foot and Mouth Disease (FMD) is globally pandemic which badly affect the economics of livestock based countries like Pakistan. There are different types of Foot and Mouth Disease Virus (FMDV) among these types O is most prevalent in Pakistan. Recently Pakistan is producing approximately fifteen million doses of non-purified FMD vaccine against the demand of 160 million doses annually. More over the Pakistan is still striving for the development and optimization of concentration as well as purification of FMDV. The present project was designed to develop the technology for the purification of FMDV indigenously. The locally isolated and adapted FMDV type O virus was propagated on adherent culture of BHK-21cells to get final volume of virus one liter. This virus suspension was concentrated by peggylation as well as ultra-filtration method. The purification and quantification of concentrated virus was done by size exclusion chromatography. The results showed that peggylation is better method of concentration up to 603.75 µg/ml with 82.80 % recovery rate than ultra-filtration with 43.90 % followed by chromatography for purification. The PD was calculated in bovines at 24, 12, 6, 3 and 1.5 µg of FMDV Ag/dose and it revealed that antigen load of 1.98 µg is the dose, where the 50 % of inoculated animals showed the protective antibody level based upon percent inhibition through antibody detecting ELISA. According to the British pharmacopeia, the vaccine should contain 3PD which found equivalent to our findings about 6 µg/dose. The group of animal injected with 6/dose (3.23PD50) showed protective titer up to 20th week post priming.

摘要

口蹄疫在全球流行,严重影响了像巴基斯坦这样以畜牧业为主的国家的经济。口蹄疫病毒(FMDV)有不同类型,其中O型在巴基斯坦最为普遍。最近,巴基斯坦每年生产约1500万剂非纯化口蹄疫疫苗,而每年的需求量为1.6亿剂。此外,巴基斯坦仍在努力开发和优化口蹄疫病毒的浓缩及纯化方法。本项目旨在自主研发口蹄疫病毒的纯化技术。将本地分离并适应的O型口蹄疫病毒在BHK - 21细胞的贴壁培养物上增殖,以获得1升病毒终体积。该病毒悬液通过聚乙二醇化以及超滤方法进行浓缩。浓缩病毒的纯化和定量通过尺寸排阻色谱法进行。结果表明,聚乙二醇化是更好的浓缩方法,浓缩至603.75μg/ml,回收率为82.80%,优于超滤法(回收率43.90%),随后通过色谱法进行纯化。在牛身上以24、12、6、3和1.5μg口蹄疫病毒抗原/剂量计算PD,结果显示抗原负荷为1.98μg时为该剂量,在此剂量下,50%的接种动物通过抗体检测ELISA基于抑制百分比显示出保护性抗体水平。根据英国药典,疫苗应含有3PD,这与我们发现的约6μg/剂量相当。注射6μg/剂量(3.23PD50)的动物组在初次免疫后第20周显示出保护性滴度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/8e6e57403f1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/011199ae54e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/69572d6e08c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/8e6e57403f1f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/011199ae54e6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/69572d6e08c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e350/10333673/8e6e57403f1f/gr3.jpg

相似文献

1
Preparation of purified vaccine from local isolate of foot and mouth disease virus and its immune response in bovine calves.用口蹄疫病毒本地分离株制备纯化疫苗及其在犊牛中的免疫反应。
Saudi J Biol Sci. 2023 Jul;30(7):103709. doi: 10.1016/j.sjbs.2023.103709. Epub 2023 Jun 16.
2
Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.口蹄疫病毒(亚洲1型血清型)病毒样颗粒疫苗在大肠杆菌中的大规模生产及在牛中的免疫保护效力评估
BMC Biotechnol. 2016 Jul 2;16(1):56. doi: 10.1186/s12896-016-0285-6.
3
Development and modeling of two-dimensional fast protein liquid chromatography for producing nonstructural protein-free food-and-mouth diseases virus vaccine.二维快速蛋白质液相色谱法的建立与建模及其在生产无结构蛋白口蹄疫疫苗中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 1;1096:113-121. doi: 10.1016/j.jchromb.2018.08.014. Epub 2018 Aug 21.
4
The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.免疫增强剂 CVC1302 增强了猪口蹄疫病毒疫苗的免疫效果和保护能力。
Vaccine. 2018 Dec 18;36(52):7929-7935. doi: 10.1016/j.vaccine.2018.11.012. Epub 2018 Nov 20.
5
Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.高免疫原性 O1 曼萨那单价疫苗对绵羊感染 O/SEA/Mya-98 谱系口蹄疫病毒的效力。
Antiviral Res. 2017 Sep;145:114-122. doi: 10.1016/j.antiviral.2017.07.020. Epub 2017 Aug 3.
6
Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods.与传统方法相比,验证γ辐射和紫外线作为口蹄疫病毒的新型灭活剂。
Vet World. 2015 Sep;8(9):1088-98. doi: 10.14202/vetworld.2015.1088-1098. Epub 2015 Sep 19.
7
Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.工程化A型口蹄疫病毒疫苗对猪体内两种大流行毒株的交叉保护效力
Vaccine. 2015 Oct 26;33(43):5772-5778. doi: 10.1016/j.vaccine.2015.09.055. Epub 2015 Oct 1.
8
Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine.基于三价口蹄疫疫苗的开发和血清学效力评估。
Vaccine. 2020 Jul 6;38(32):4970-4978. doi: 10.1016/j.vaccine.2020.05.079. Epub 2020 Jun 10.
9
Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.用表达口蹄疫病毒衣壳前体编码区的减毒重组伪狂犬病病毒免疫猪诱导保护性免疫。
Vaccine. 2008 May 23;26(22):2714-22. doi: 10.1016/j.vaccine.2008.03.020. Epub 2008 Apr 1.
10
Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.细胞密度对悬浮细胞中口蹄疫病毒 O 型 146S 组分的生物学滴度和产量的影响。
J Virol Methods. 2022 Feb;300:114379. doi: 10.1016/j.jviromet.2021.114379. Epub 2021 Nov 24.

引用本文的文献

1
Protein characterization of an Indonesian isolate of foot and mouth disease virus inactivated with formaldehyde and binary ethylenimine.用甲醛和双乙烯亚胺灭活的印度尼西亚口蹄疫病毒分离株的蛋白质特性分析
Vet World. 2024 Aug;17(8):1836-1845. doi: 10.14202/vetworld.2024.1836-1845. Epub 2024 Aug 24.
2
Inactivation of an Indonesian isolate of foot-and-mouth disease virus using formaldehyde.使用甲醛灭活一株印度尼西亚口蹄疫病毒分离株
Vet World. 2024 Jun;17(6):1190-1195. doi: 10.14202/vetworld.2024.1190-1195. Epub 2024 Jun 2.
3
Conservation and upgradation of indigenous Cholistani cattle breed of Pakistan: a pathway to sustainable livestock.

本文引用的文献

1
Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens.氯仿去除口蹄疫病毒非结构蛋白及高纯度疫苗抗原放大生产的相关因素
Vaccines (Basel). 2022 Jun 24;10(7):1018. doi: 10.3390/vaccines10071018.
2
An Improved αvβ6-Receptor-Expressing Suspension Cell Line for Foot-and-Mouth Disease Vaccine Production.一种改良的αvβ6 受体表达悬浮细胞系,用于口蹄疫疫苗生产。
Viruses. 2022 Mar 16;14(3):621. doi: 10.3390/v14030621.
3
Evaluation of Potency and Duration of Immunity Elicited by a Multivalent FMD Vaccine for Use in South Africa.
保护和改良巴基斯坦本土 Cholistani 牛品种:实现可持续畜牧业的途径。
Trop Anim Health Prod. 2024 May 10;56(4):157. doi: 10.1007/s11250-024-04013-y.
用于南非的多价口蹄疫疫苗所引发的免疫效力和持续时间评估。
Front Vet Sci. 2021 Dec 15;8:750223. doi: 10.3389/fvets.2021.750223. eCollection 2021.
4
The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.东非地区天然稳定的口蹄疫候选疫苗株的选择。
Vaccine. 2021 Aug 16;39(35):5015-5024. doi: 10.1016/j.vaccine.2021.07.001. Epub 2021 Jul 21.
5
Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor.在生物反应器中使用适应悬浮培养的BHK-21细胞生产口蹄疫疫苗抗原
Vaccines (Basel). 2021 May 13;9(5):505. doi: 10.3390/vaccines9050505.
6
Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses.肝素亲和层析在制备 O 型口蹄疫病毒非结构蛋白无抗体诱导差减疫苗中的应用
Viruses. 2020 Dec 7;12(12):1405. doi: 10.3390/v12121405.
7
Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency.新型口蹄疫疫苗平台:用于安全且符合鉴别诊断要求的高效口蹄疫疫苗的配方
Front Vet Sci. 2020 Sep 25;7:554305. doi: 10.3389/fvets.2020.554305. eCollection 2020.
8
Effect of formaldehyde and binary ethyleneimine (BEI) on the integrity of foot and mouth disease virus capsid.甲醛和双乙烯亚胺(BEI)对口蹄疫病毒衣壳完整性的影响。
Rev Sci Tech. 1989 Jan;8(3):747-764. doi: 10.20506/rst.8.3.425.
9
Determination of the optimal method for the concentration and purification of 146S particles for foot-and-mouth disease vaccine production.确定用于口蹄疫疫苗生产的 146S 颗粒浓缩和纯化的最佳方法。
J Virol Methods. 2019 Jul;269:26-29. doi: 10.1016/j.jviromet.2019.04.009. Epub 2019 Apr 8.
10
Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.高免疫原性多价口蹄疫病毒疫苗对牛的效力,针对的是来自新兴 A/ASIA/G-VII 谱系的田间病毒的异源挑战。
Vaccine. 2018 Mar 27;36(14):1901-1907. doi: 10.1016/j.vaccine.2018.02.016. Epub 2018 Mar 2.